Close
Smartlab Europe
Inizio Ignite

News

Truking celebrates 20 years

Truking is celebrating its 20th anniversary with the ground-breaking dig for a new construction project. The pharmaceutical machinery manufacturer is extending its industrial park in the central Chinese city of Changsha, where eight new buildings will go up within...

Albumedix announces jonas skjodt moller as new Chief Executive Officer

Albumedix Ltd. , the world leader in recombinant human albumin (rAlb), announced its succession plan as Peter Rosholm, after 13 years leading the company, has decided to step down as CEO and handover the company’s leadership. Peter’ successor as...

Vetter wins Axia Best Managed Company Award

A look at vital figures makes it clear that Vetter is a very successful, globally active Contract Development and Manufacturing Organization (CDMO). Over the last ten years, the company has more than doubled its annual sales revenues to approximately...

GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio

GlaxoSmithKline and Samsung Biologics have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSK’s innovative biopharmaceutical therapies. Under the terms of the agreement, Samsung Biologics will provide GSK with additional capacity for large-scale biopharmaceutical...

Roche’s Port Delivery System with ranibizumab shows positive phase III results in neovascular age-related macular degeneration

Roche announced positive topline results from the phase III Archway study, evaluating Port Delivery System with ranibizumab (PDS) in people living with neovascular or “wet” age-related macular degeneration (nAMD). PDS is a permanent refillable eye implant, approximately the size...

Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine

Novavax, Inc. , a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX CoV2373, a stable, prefusion protein made using...

Thermo Fisher Scientific Extends Collaboration with Biognosys to Enhance Protein Quantitation Mass Spectrometry Workflows

Thermo Fisher Scientific, the world leader in serving science, and Biognosys, a leading developer of next-generation proteomics solutions, announce they are continuing their collaboration to advance data independent acquisition (DIA) mass spectrometry-based workflows. Together, the companies have developed a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »